ArticleFrontiers in medicine2025

Evaluation of the efficacy as well as prognosis of targeted therapy for advanced non-small cell lung cancer patients with different expression of miR-183 family in body fluids.

Min Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.